• Management Experienced in Global eCommerce Business Development. 
• Completed Reg A Filing to Raise $1.5 Million Funding for Acquisitions.
• New Focus on Incubating High Revenue Scalable Companies in Growing Markets, Then Spinning Them Off Through the Issuance of FREE DIVIDEND Shares to Existing CYAP Shareholders of Record.
• Plans in Play to Launch Price Comparison Website for Major Names Including Amazon, Nordstrom and Home Depot.

Cyber Apps World, Inc. (OTC: CYAP) is dedicated to acquiring and developing a global eCommerce internet platform with the purchase and sale of products and services by way of mobile/computer applications worldwide. CYAP anticipates making available to subscribers, an ever-growing list of applications and programs.

On November 17th CYAP announced that it is now ready to embark on a new business plan. CYAP is focused on using strategic investment strategies to fund, incubate, launch, and grow profitable, multiple businesses as wholly-owned subsidiaries and then spin them off, which will enable the company to issue free dividend shares to all CYAP shareholder. There’s nothing sweeter in the stock market than getting free shares just for being a shareholder. 

So far, CYAP has completed an internal re-organization, secured executives with significant specific experience, qualified a Regulation A offering priced to raise $1.5 million dollars at $.40/share, and is preparing to launch its first spin-off when development is completed. Shares in the first new public entity will be issued to existing CYAP shareholders in proportion to their then current interest in CYAP, subject to and in accordance with applicable regulations. This spin-out is intended to be the first of more to come. Yes, this is a stock market “Sweet Spot.” 

• Poised to Commence High Value Acquisitions Under the Guidance of Seasoned Management

CYAP has already identified a series of acquisitions targeting apps and online services for individuals and corporations alike and has obtained the services of a seasoned industry executive with experience in these specific areas to negotiate and enter into asset purchase agreements.

Mohammed Irfan Rafimiya Kazi has acted as the CYAP President, CEO, CFO, and as a director since March 10, 2020. From January 2012 to February 2020, Mr. Kazi acted as a website developer and technical manager for various companies, including Nuclear Power Corporation of India, and E-Digix Technologies Pvt. Ltd., all of which are based in India.

• $1.5 Million Funding Plan in Play for Acquisitions and Development

The funding of up to $1.5 million dollars pursuant to the qualified CYAP Regulation A offering will, subject to successful completion, enable the company to acquire or found, incubate, and launch various products or services and become revenue positive subsidiaries.

Presently, CYAP management is excited about launching its dynamic real-time price comparison SmartSaveNow website and app. A price comparison website, also known as comparison shopping website, comparison shopping agent, price analysis tool, or comparison shopping platform, is a platform where a user can employ filters to compare products on the basis of features, reviews, price, and other factors. Price comparison websites are online platforms where all data related to certain consumer goods are merged so that the user does not need to access individual websites to compare products.

The CYAP SmartSaveNow app will provide users with the lowest real-time price on all its items. Customers will no longer need access multiple sites to find the lowest price for an item. The price comparison website market is expected to increase at a significant growth rate during the upcoming years. SmartSaveNow will first launch in the USA and then other countries all over the world. The application has been developed with a view to rapid expansion into other countries. The global price comparison website market is supported by various growth drivers, such as increased internet penetration, smartphone use, and increasing market switching.

• Growing Interest on a Worldwide Scale for Price Comparison Website Business Reaching Above the $1.5 Billion Transaction Level

Price comparison websites have become increasingly popular around the world over the last ten years. In the United Kingdom and the United States, market research groups have estimated that $1.5 billion in transactions pass through this well-established industry annually, according to Wize Commerce. 

The CYAP SmartSaveNow's mission is to provide the lowest real-time price on all consumer items it offers for sale through its website. Customers will have the confidence that when shopping online with smartsavenow.com, they will not have to price compare at multiple sites for an item. The SmartSaveNow.com  website will launch in the USA with over 25 million items and provide customers real-time prices from websites like Wal-Mart, Best Buy, EBay, Target and others, guaranteeing the lowest price for an item at that particular time.

In the USA, SmartSaveNow expects to be approved by over 90 sellers including Amazon, Nordstrom and Home Depot. Additionally, in nine countries including Canada, UK, Germany, SmartSaveNow intends to be approved by over 500 sellers.

The all new CYAP platform has been developed to operate on iOS, Android, and personal computers. After its initial launch in the USA, SmartSaveNow intends to launch in an additional nine countries within five months. CYAP is the definition of a ground floor opportunity that could lift early investors sky high.     

For more information on Cyber Apps World, Inc. (OTC: CYAP) visit:   https://cyberappsworld.com/

###

January 17, 2020

Buying or selling a home is a huge decision. This is especially true when selling a home in a distressed situation or when someone is a highly motivated buyer. The good news is in the extended Polk, Ohio area help is out there waiting to deliver a professional hand. The89Housebuyer.com has been winning praise for their ability to close sales selling and buying homes without their needing to be listed to the benefit of all involved.

“We buy homes when people need money fast,” commented Jason Betts from The89Housebuyer.com. “We are here when there’s a need and we are always upfront and transparent.”

According to the office some key reasons they are called on include: when they have little or no equity, face a job transfer, are going through a divorce, have property from an estate sale, and are faced with two house payments, among many other reasons.

To learn more be sure to visit www.The89Housebuyer.com

###

• BioPharma Company with Worldwide Patents on Effective Cancer Drugs. 
• Joint Agreement to Advance Cancer Treatment to Clinical Trials in Canada.
• New Distribution of Nutritional Supplements in Asia and the Far East.
• Developing New Anti-Coronavirus Drug with the University of Georgia.
• $2 Million Financing in Place to Support Anti-Coronavirus Program.

Sunshine Biopharma (OTC: SBFM) is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, SBFM is engaged in the development and commercialization of science-based nutritional supplements and is also currently engaged in the development of a new pharmaceutical to treat infections of the Covid-19 Coronavirus. 

Since inception, SBFM has been involved in the development of Adva-27a, a small molecule that has been shown to be exceptionally effective at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). SBFM is a direct owner of all worldwide patents covering Adva-27a, including all issued and pending patents.

• Agreement with a Montreal-based Company to Advance the Highly Promising Development of Adva-27a Anticancer Compound

On November 18^th SBFM announced a collaboration agreement with a Montreal-based company for the purposes of advancing the development of the SBFM anticancer compound, Adva-27a. The goal of this collaboration is to develop and implement chemical synthesis procedures for Adva-27a and test the resulting material in various types of cancer cells grown in culture. Based on the cell culture results, the SBFM drug development partner will conduct mice studies in preparation for entry of Adva-27a into clinical trials. It is anticipated that the clinical trials will be for Stage IV pancreatic cancer indication and will be performed at McGill University's Jewish General Hospital in Montreal, Canada.

• Distribution of High Value Essential-9(TM) in Asia and the Far East

On November 10^th SBFM announced an agreement with JOAH International Pte., Ltd., headquartered in Singapore, for distribution of Essential-9tm in Asia and the Far East. The SBFM Essential-9tm is a nutritional supplement tablet comprised of a balanced formula of the 9 essential amino acids that the human body cannot make. Essential-9tm is authorized for marketing by Health Canada under NPN 80089663.

Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis. Proteins are involved in all body functions - From the musculature and immune system to hormones and neurotransmitters. Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, chronic fatigue, weight gain, and weakened immune system. The SBFM Essential-9TM provides a balanced formula of all 9 Essential Amino Acids in free-form, ready to be absorbed. Essential-9tm is suitable for everyone: Vegans, Seniors, Dieters, Athletes, and everyone looking to increase their health. In North America, Essential-9tm is available on Amazon.com and Amazon.ca.

• Sunshine Biopharma and the University of Georgia Team Up to Develop New and Vitally Needed Anti-Coronavirus Drug

On October 19^th SBFM announced an agreement with the University of Georgia to advance the development of the company’s recently announced Anti-Coronavirus lead compound, SBFM-PL4. The goal of this cutting-edge collaboration is to develop SBFM-PL4, a protease inhibitor, as a treatment for Coronavirus infections. This new treatment is based on the technology described in recently filed SBFM patent application covering small molecules which can be used to treat Coronavirus infections. Sunshine's SBFM-PL4, will be put through a series of in vitro tests to evaluate its specific inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro), one of two Coronavirus encoded proteases essential for viral replication. Following the initial in vitro studies, SBFM-PL4 will be moved forward to the cell culture testing stage and assessment in Coronavirus infected mice before entering human clinical trials.

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative agent of COVID-19, the current pandemic. There are currently no drugs that can effectively arrest replication of the virus in people who have contracted the illness. On May 22nd SBFM filed a provisional patent application for a library of molecules which were designed to inhibit the Coronavirus proteases, thus shutting down the ability of the virus to multiply and cause illness.

• Sunshine Biopharma Secures $2,000,000 + Financing for Critical Coronavirus Treatment

On September 15^th SBFM announced that it has received the first tranche of $250,000 as part of a committed minimum financing of $2 Million with RB Capital Partners Inc. Under the agreement RB Capital has agreed to provide funding to SBFM in the form of convertible promissory notes (the "Promissory Notes"). The Promissory Notes will bear interest at the rate of 5% per annum and will be fully convertible into shares of the Company's Common Stock at a conversion price equal to the market value on the applicable conversion date or $0.30 per share, whichever is greater. The Promissory Notes will have a maturity date of two years from the date of issuance and must be fully converted on or before the maturity date. SBFM reserves the right to pay off any part or all of the Promissory Notes at any time without penalty. The minimum amount of funding that RB Capital has agreed to provide to SBFM under these terms is $2,000,000, payable over the next three to six month period.

The proceeds will be used for development of the SBFM Coronavirus treatment on a priority basis and the clinical development of Adva-27a, the Company's flagship anticancer compound targeted for pancreatic cancer.

For more information on Sunshine Biopharma (OTC: SBFM) visit:  http://www.sunshinebiopharma.com

###              

She’s stunning, smart and successful, but Chloe Othen is more than just a pretty face. The former Miss World Next Top Model 2019 is also an entrepreneur, model, ambassador and has six other national titles to her name.

A woman who values time and exudes opulence, Chloe has been selected to become the newest face of Pacha of London, a well-respected name in the luxury watch industry.

Located in the heart of the world famous jeweller district Hatton Garden, Pacha of London has been selling some of the most valued and rare collectible timepieces and diamonds from brands like Richard Mille, Audemars Piguet, Rolex, Patek Philippe, Cartier and Hublot.

The blonde bombshell from London has been modelling and competing in beauty pageants internationally for over 10 years and started to turn heads after she won Miss Earth England in 2013.

Ms Othen has also graced the pages of Vogue and the catwalks of London Fashion Week, and currently represents brands on her social media accounts, including her Instagram @chloeothen, making the decision to select her as Pacha of London’s brand ambassador even more fitting.

She will now be the face of the company’s new campaigns, wearing the most beautiful watches the world has ever seen and can’t wait to begin her ambassadorship.

“I am absolutely honored to be chosen as the face of Pacha of London as it aligns with my brand ethos,” Ms Othen said.

The jewellery brand has been known in London for over fifteen years and has solidified its credibility as one of the top suppliers of high quality timepieces and for its high level of customer service in the city.

The partnership between Chloe Othen and Pacha of London will surely be one to watch.

“Chloe was an obvious choice as a brand ambassador as she oozes class, sophistication and carries herself elegantly; therefore a perfect fit for Pacha,” Pacha of London Director, Bora Guccuk said.

Ms Othen also hopes to inspire more women around the world to follow their dreams and work as hard as they can to live the life that she now enjoys, one that’s full of luxury.

Follow @pacha_of_londonjewelers to know more about the brand.

###

TRENTON, NJ, DECEMBER 02, 2020 - Michal “Michael” Zasowski, a certified New Jersey probate real estate specialist with MTI education and CPE – Probate Mastery Training has launched a new website https://www.njprobatesource.com. Michal created this website especially for people who are going through a very hard time in their lives, especially after the loss of a close and dear one.

Having acquired extensive training and experience, he was awarded the top spot in residential sales - the Certified Residential Specialist (CRS). Such rare is this award that only an astounding 4% of the realtors in all of the United States can call themselves CRS. With his team, he has represented every facet of the industry and has earned remarkable success, so much that he was also featured in the media.

Equipped with a system that is remarkably successful, NJ Probate Source of Professionals are here to guide you not only through your troubling times but also help you execute your most important decisions by helping you understand core facts of what you have at hand. As you navigate the stressful waters, an experienced probate specialist right next to you will make you feel confident and, of course, less alone.

"I am glad of the work we have done so far. We help you realize the most important aspects and objectives regarding the real estate involved in probate. Whether you want a fast sale or otherwise, we are always prepared to bring to you qualified investors according to the sale process you are looking for and how you want your finances managed. All listings and aggressive marketing is taken care of by us and, subject to courts and other timelines, we will help you to find investors within 24 hours. With the experience, connections and skills of NJ Probate Source, we promise you the smoothest transition for your real estate", said Michal Zasowski.

For more information, please visit https://www.njprobatesource.com/

About 

NJ Probate Source is headed by Michal Zasowski who is a certified New Jersey probate real estate specialist with MTI education and CPE – Probate Mastery Training. He helps people, executors and personal representatives make important real estate decisions.

Contact

Name - Michal Zasowski

Phone Number - 1-800-246-0647

Email - Mike@Njprobatesource.Com

###